Literature DB >> 18600508

Urate transport across the apical membrane of renal proximal tubules.

Hitoshi Endou1, Naohiko Anzai.   

Abstract

Since the molecular cloning of the renal apical urate/anion exchanger URAT1 (SLC22A12), several membrane proteins relevant to urate transport have been identified. In addition, the identification of PDZ (PSD-95, DglA, and ZO-1) domain protein PDZK1 as a binding partner of URAT1, and the emerging role of PDZ scaffold for renal apical transporters have led to a new concept of renal urate transport: urate-transporting multimolecular complex, or "urate transportsome," that may form an ultimate functional unit at the apical membrane of renal proximal tubules. Elucidation of urate transportsome will lead to the new drug development for hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600508     DOI: 10.1080/15257770802136024

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  16 in total

1.  Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

Authors:  Kate Witkowska; Kyla M Smith; Sylvia Y M Yao; Amy M L Ng; Debbie O'Neill; Edward Karpinski; James D Young; Christopher I Cheeseman
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

2.  A sugar transporter regulates serum urate levels: implications for prevention and management of hyperuricemia in gout.

Authors:  Robert A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 3.  Genetics of hyperuricemia and gout: implications for the present and future.

Authors:  Ronald L George; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

5.  Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers.

Authors:  Kristin J Bergsland; Fredric L Coe; Joan H Parks; John R Asplin; Elaine M Worcester
Journal:  Nephrol Dial Transplant       Date:  2018-05-01       Impact factor: 5.992

Review 6.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

7.  Latest evidence on gout management: what the clinician needs to know.

Authors:  Christopher M Burns; Robert L Wortmann
Journal:  Ther Adv Chronic Dis       Date:  2012-11       Impact factor: 5.091

Review 8.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

Review 9.  The genetics of hyperuricaemia and gout.

Authors:  Anthony M Reginato; David B Mount; Irene Yang; Hyon K Choi
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

Review 10.  Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.